Wnt signaling in cancer.
Open accessThe DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
Background
Cited by
Items 401–500 of 859
Wang, Z.-Q., Sun, X.-L., Wang, Y., & Miao, Y.-L. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1811325 · Cited by 27
“Numerous evidences have confirmed that WNT pathway plays a fundamental role in a wide range of human malignancies via regulating tumor cell proliferation and cell polarity [24].”
BackgroundWang, Z., Zhang, M., Luo, W., Zhang, Y., & Ji, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00046 · Cited by 27
Hallmark discoveries in the biology of Wilms tumour
Perotti, D., Williams, R. D., Wegert, J., Brzezinski, J. J., Maschietto, M. C., Ciceri, S., Gisselsson, D., Gadd, S., Walz, A. L., Furtwängler, R., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00824-0 · Cited by 35
Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma
Kojima‐Yuasa, A., Huang, X., & Matsui‐Yuasa, I. (2015) · Diseases · doi:10.3390/diseases3040260 · Cited by 28
“They involve multiple cellular signaling pathways, including the Wnt/β-catenin signaling pathway [2], p53 expression [3], Ras/mitogen-activated protein kinase (MAPK) pathway [4], activation of the retinoblastoma protein (pRb) [5], and signal transducer and activator of transcription 3 (STAT3) [6].”
Stuckenholz, C., Lu, L., Thakur, P. C., Choi, T. Y., Shin, D., & Bahary, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062470 · Cited by 28
Connor, A. E., Baumgartner, R., Baumgartner, K. B., Kerber, R. A., Pinkston, C. M., John, E. M., Torres-Mejía, G., Hines, L. M., Giuliano, A. R., Wolff, R. K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2299-7 · Cited by 31
“While, mutations within the Wnt pathway are rare in breast cancer, there is evidence for hyperactive signaling, especially in triple negative [estrogen receptor (ER), progesterone receptor (PR), and HER2 negative] or basal-like breast cancers [11–14].”
BackgroundSporadic early-onset colon cancer expresses unique molecular features
Jandová, J., Xu, W., & Nfonsam, V. N. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.04.068 · Cited by 25
SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression
Taye, N., Alam, A., Ghorai, S., Chatterji, D. G., Parulekar, A., Mogare, D., Singh, S., Sengupta, P., Chatterjee, S., Bhat, M. K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25093 · Cited by 27
UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
Yu, Y. H., Xu, P., Cui, G., Xu, X., Li, K., Chen, X., & Bao, J. (2020) · Cancer Cell International · doi:10.1186/s12935-019-1078-5 · Cited by 27
CDK1‐mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling
Chen, J., Rajasekaran, M., Xia, H., Kong, S. N., Deivasigamani, A., Sekar, K., Gao, H., Swa, H. L. F., Gunaratne, J., Ooi, L. L., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899395 · Cited by 27
“Moreover, mitotic Wnt signalling negative regulators that were confirmed here, including APC, Axin1 or CK I a , are frequently mutated in human cancers (Polakis, 2012).”
Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli
Kariv, R., Caspi, M., Isakov, N. F., Shorer, Y., Shor, Y., Rosner, G., Brazowski, E., Beer, G., Cohen, S., & Rosin‐Arbesfeld, R. (2019) · International Journal of Cancer · doi:10.1002/ijc.32557 · Cited by 27
“to the overexpression of Wnt target genes, some of which are involved in proliferation.(12) More than 2,500 germline mutations in APC have been reported;(13) most of these lead to the expression of a truncated protein as a result of frameshift or nonsense mutations.”
BackgroundZhang, W., Peng, C., Yan, J., Chen, P., Jiang, C., Sang, S., Yuan, Y., Hong, Y., & Yao, M. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153844 · Cited by 26
Arend, R. C., Dholakia, J., Castro, C., Matulonis, U. A., Hamilton, E. P., Jackson, C. G., Lybarger, K., Goodman, H. M., Duska, L., Mahdi, H., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.03.013 · Cited by 31
NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling
Stančíková, J., Krausová, M., Kolář, M., Fafílek, B., Švec, J., Sedláček, R., Neřoldová, M., Dobeš, J., Horázná, M., Janečková, L., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.008 · Cited by 27
Oliveira, M. L., Akkapeddi, P., Alcobia, I., Almeida, A. R. M., Cardoso, B. A., Fragoso, R., Serafim, T. L., & Barata, J. T. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.011 · Cited by 29
Kling, J. C., Jordan, M. A., Pitt, L. A., Meiners, J., Thanh-Tran, T., Tran, L. S., Nguyen, T. T. K., Mittal, D., Villani, R. M., Steptoe, R. J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00483 · Cited by 29
Han, M., Wang, H., Zhang, H.-T., & Han, Z. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.123 · Cited by 25
“Beta-catenin is a multifunctional protein that contributes fundamentally to embryonic development and many physiological or pathophysiological processes [1].”
BackgroundRNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line
Lichawska-Cieślar, A., Pietrzycka, R., Ligęza, J., Kulecka, M., Paziewska, A., Kalita, A. I., Dolicka, D., Wilamowski, M., Miękus, K., Ostrowski, J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24269 · Cited by 25
“FRAT1 and RIPK4 modulate the Wnt signaling pathway, which is a crucial player in initiation and development of many cancers [101].”
BackgroundCui, J., Pan, G., He, Q., Yin, L., Guo, R., & Bi, H. (2019) · Oncology Letters · doi:10.3892/ol.2019.10619 · Cited by 30
“Accumulated evidence demonstrate that aberrant activation of the Wnt/β-catenin pathway could result in tumor formation (30).”
Jugait, S., Areti, A., Nellaiappan, K., Narwani, P., Saha, P., Ravichandiran, V., & Kumar, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02858-8 · Cited by 25
Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo
Rowson-Hodel, A. R., Manjarín, R., Trott, J. F., Cardiff, R. D., Borowsky, A., & Hovey, R. C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1572-7 · Cited by 25
“Although squamous differentiation is rare among human breast carcinomas, it is a phenotype that has been linked to Wnt activation [55], which has been associated with basal-like and receptor negative breast cancers [56].”
BackgroundArchbold, H. C., Broussard, C., Chang, M. V., & Cadigan, K. M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004591 · Cited by 31
Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation
Ali, I., Fagla, B. M., & Braun, D. P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040495 · Cited by 27
Intestinal Organoids—Current and Future Applications
Meneses, A. M. C., Schneeberger, K., Kruitwagen, H. S., Penning, L. C., van Steenbeek, F. G., Burgener, I. A., & Spee, B. (2016) · Veterinary Sciences · doi:10.3390/vetsci3040031 · Cited by 31
“Other studies have employed CRISPR/Cas9-mediated gene editing of healthy organoids to directly evaluate candidate gene function in tissue physiology and carcinogenesis [47].”
BackgroundMartin, H. L., Bedford, R., Heseltine, S. J., Tang, A. A.-S., Haza, K. Z., Rao, A., McPherson, M. J., & Tomlinson, D. C. (2018) · New Biotechnology · doi:10.1016/j.nbt.2018.02.008 · Cited by 25
“Over the last 20 years it has become clear that Wnt signalling is dysregulated in a number of cancers, notably colorectal but also breast and hepatocellular cancer [65].”
BackgroundDown-regulation of the Wnt/β-catenin signaling pathway by Cacnb4
Rima, M., Daghsni, M., Lopez, A., Fajloun, Z., Lefrançois, L., Duñach, M., Mori, Y., Merle, P., Brusés, J. L., WAARD, M. M. D., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-01-0076 · Cited by 29
“Wnt-responsive genes play a major role in basic cellular events such as cell proliferation, and abnormal Wnt signaling has been shown to be responsible for a number of pathologies including cancers (Polakis, 2012) and neurological diseases (Kalkman, 2012).”
BackgroundPyMT-1099, a versatile murine cell model for EMT in breast cancer
Saxena, M. T., Kalathur, R. K. R., Neutzner, M., & Christofori, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-30640-1 · Cited by 26
Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.
Kim, J., Naini, F. A., Sun, Y., & Ma, L. (2018) · Europe PMC (PubMed Central) · Cited by 24
Gómez-Cambronero, J., & Kantonen, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2vmr0214-120rr · Cited by 23
“We propose that PLD2 is a downstream effector in the Wnt pathway with PLD2 inhibiting Wnt, and Wnt is an integral protein to the Wnt/ -catenin signaling pathway, which regulates gene expression and actin anchoring [35, 36], whereas the disruption of this pathway leads to senescence [19, 37].”
BackgroundFAM3C : An Emerging Biomarker and Potential Therapeutic Target for Cancer
Zhu, Y., Pu, Z., Wang, G., Li, Y., Wang, Y., Li, N., & Peng, F. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0179 · Cited by 28
LncRNA PVT1: as a therapeutic target for breast cancer
Baljon, K. J., Ramaiah, P., Saleh, E. A. M., Al-dolaimy, F., Al-Dami, F. H., Gandla, K., Alkhafaji, A. T., Abbas, A. H. R., Alsaalamy, A. H., & Bisht, Y. S. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154675 · Cited by 23
Structure-Function Analysis of the C-clamp of TCF/Pangolin in Wnt/ß-catenin Signaling
Ravindranath, A. J., & Cadigan, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086180 · Cited by 26
“Misregulation of the pathway is implicated in many diseases in humans, including many cancers [7,9], bone disorders [10] and type II diabetes [11].”
BackgroundCore and specific network markers of carcinogenesis from multiple cancer samples
Wong, Y.-H., Chen, R.-H., & Chen, B. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.05.045 · Cited by 24
Peng, L., Huang, Y., Zhang, F., Chen, J., & Huo, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s171200 · Cited by 23
“Mutations in some components of Wnt/β-catenin pathway, such as mutation of β-catenin at position Ser45 or mutations in APC or Axin, have been described in cancers and considered as inappropriate activation of the Wnt pathway.(64) However, present consensus is that the direct mutagenic effect of Cd is weak or just rest…”
Braggio, D., de Faria, F. C. C., Koller, D., Jin, F., Zewdu, A., Lopez, G., Batte, K., Casadei, L., Welliver, M. X., Horrigan, S. K., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276047 · Cited by 26
Ramakrishnan, A., Burby, P. E., Adiga, K., & Cadigan, K. M. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102735 · Cited by 29
Wu, W., Li, H., Wang, Z., Dai, Z., Liang, X., Luo, P., Liu, K., Zhang, H., Zhang, N., Li, S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23915 · Cited by 26
“For example, MAPK signaling pathway, ERBB signaling pathway, and WNT signaling pathway were significantly upregulated [19,20].”
BackgroundMelatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer
Martínez‐Campa, C., Garcia, V. A., Alonso‐González, C., González, A., & Cos, S. (2024) · Cancers · doi:10.3390/cancers16050956 · Cited by 27
“In the absence of Wnt ligands, ubiquitin-dependent proteasome degradation keeps the β -catenin protein at its basal levels [70].”
Background14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway
Gong, F., WANG, G., Ye, J., Li, T., Bai, H., & Wang, W. (2013) · Oncology Reports · doi:10.3892/or.2013.2740 · Cited by 26
Targeting Tankyrase to Fight WNT ‐dependent Tumours
Thorvaldsen, T. E. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12786 · Cited by 26
“Mutations in the genes encoding axis inhibition protein 1 (AXIN1), axis inhibition protein 2 (AXIN2) or β-catenin have also been identified in a subset of CRCs and several other cancer types [9].”
BackgroundFlanagan, D. J., Barker, N., Nowell, C. J., Clevers, H. C., Ernst, M., Phesse, T. J., & Vincan, E. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029876 · Cited by 36
“Wnt signalling has to be tightly regulated during homeostasis, as deregulated Wnt signalling is often one of the earliest oncogenic events in several cancers (Polakis, 2012).”
BackgroundAmawi, H. A., Hussein, N. A., Karthikeyan, C., Manivannan, E., Wisner, A. S., Williams, F. E., Samuel, T., Trivedi, P., Ashby, C. R., & Tiwari, A. K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00498 · Cited by 22
“β-catenin, a key regulator protein, is translocated to the nucleus after activation, where it binds to the T-cell factor/lymphoid enhancer factor (TCF/LEF) complex and induces the expression of several oncogenes, including c-Myc, which promote cancer and metastasis (Polakis, 2012).”
BackgroundGuo, W., Shen, F., Xiao, W., Chen, J., & Pan, F. (2017) · Oncology Letters · doi:10.3892/ol.2017.7100 · Cited by 25
“…options for patients with SCLC. Aberrant activation of Wnt signaling, which serves a key function in the regulation of cell viability, development and differentiation, has been associated with a number of types of cancer including colorectal, prostate, liver, and breast cancer (10,11,26,27).”
Expression of Wnt-signaling pathway genes and their associations with miRNAs in colorectal cancer
Slattery, M. L., Mullany, L. E., Sakoda, L. C., Samowitz, W. S., Wolff, R. K., Stevens, J. R., & Herrick, J. S. (2017) · Oncotarget · doi:10.18632/oncotarget.23636 · Cited by 24
MNX1 promotes cell proliferation and activates Wnt/β‐catenin signaling in colorectal cancer
Yang, X., Pan, Q., Lu, Y., Jiang, X., Zhang, S., & Wu, J. (2019) · Cell Biology International · doi:10.1002/cbin.11096 · Cited by 23
“Aberrant Wnt/b-catenin signaling has been observed in multiple cancers (Polakis, 2012; Holland et al., 2013; Ramakrishnan and Cadigan, 2017).”
BackgroundRecent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer
Jebelli, A., Baradaran, B., Mosafer, J., Baghbanzadeh, A., Mokhtarzadeh, A., & Tayebi, L. (2020) · Medicinal Research Reviews · doi:10.1002/med.21735 · Cited by 24
Zhang, Q., Yin, X., & Zhang, Y. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.10.017 · Cited by 25
Bu, Q., Li, Z., Zhang, J., Xu, F., Liu, J., & Liu, H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791756 · Cited by 20
Sathyanarayanan, A., Chandrasekaran, K. S., & Karunagaran, D. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26365 · Cited by 22
Martinez-Font, E., Pérez-Capó, M., Ramos, R. F., Felipe‐Abrio, I., de España, C. G., Luna, P., Terrasa, J., Martín‐Broto, J., Vögler, O., Alemany, R., et al. (2020) · Cancers · doi:10.3390/cancers12092556 · Cited by 25
Pashirzad, M., Johnston, T. P., & Sahebkar, A. (2021) · Journal of Oncology · doi:10.1155/2021/3619510 · Cited by 23
Sporadic and Familial Adenomatous Polyposis-associated Foveolar-type Adenoma of the Stomach
Naka, T., Hashimoto, T., Cho, H., Tanabe, N., Yoshida, T., Yatabe, Y., Yoshikawa, T., Abe, S., & Sekine, S. (2022) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001949 · Cited by 22
“5 (2-87) 17/1 18/0 10/0/8 7 (39%) 8 (44%) 0 0 Flat 7 2/5 53 (50-75) 6/1/0 51 (11-87) 6/1 7/0 0/0/7 7 (100%) 7 (100%) 0 0 Raspberrylike 10 8/2 55.”
Yang, Q., Qin, T., An, T., Wu, H., Xu, G., Xiang, J., Lei, K., Zhang, S., Xia, J. L., Su, G., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175628 · Cited by 22
Identification of therapeutic targets for glioblastoma by network analysis
Friedmann‐Morvinski, D., Bhargava, V., Gupta, S., Verma, I. M., & Subramaniam, S. (2015) · Oncogene · doi:10.1038/onc.2015.119 · Cited by 22
Histone modifications induced by MDV infection at early cytolytic and latency phases
Mitra, A., Luo, J., He, Y., Gu, Y., Zhang, H., Zhao, K., Cui, K., & Song, J. (2015) · BMC Genomics · doi:10.1186/s12864-015-1492-6 · Cited by 23
“Similarly, variations in H3K27me3 levels were observed in both lines but at different time-points of infection, on genes linked to the cell proliferationassociated mitogen-activated protein (MAP) kinase signaling [16] and Wnt signaling pathways [17].”
BackgroundBirt–Hogg–Dubé syndrome and the skin
Vernooij, M., Claessens, T., Luijten, M., Steensel, M. A. M. V., & Coull, B. J. (2013) · Familial Cancer · doi:10.1007/s10689-013-9600-8 · Cited by 22
Hseu, Y., Tsou, H., Kumar, K. J. S., Lin, K., Chang, H., & Yang, H. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/197309 · Cited by 22
RetractedHawkins, A. G., Julian, C. M., Konzen, S. M., Treichel, S., Lawlor, E. R., & Bailey, K. M. (2019) · Neoplasia · doi:10.1016/j.neo.2019.08.007 · Cited by 21
Joumaa, M. M. E., Taleb, R. I., Rizk, S. E., & Borjac, J. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0143 · Cited by 27
Dawson, N. A., Zibelman, M. R., Lindsay, T., Feldman, R. A., Saul, M. E., Gatalica, Z., Korn, W. M., & Heath, E. I. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0531 · Cited by 25
“APC and CTNNB1 are important components of the Wnt pathway, which controls beta-catenin accumulation and transcription of several key genes regulating tumorigenesis, as well as up-regulating AR expression (31-33).”
BackgroundSmall-Molecule Inhibitors of Wnt Signaling Pathway: Towards Novel Anticancer Therapeutics
Zheng, S., Liu, J., Wu, Y., Huang, T. L., & Wang, G. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.159 · Cited by 25
Rahat, B., Thakur, S., Hamid, A., Bagga, R., & Kaur, J. (2016) · Epigenomics · doi:10.2217/epi.16.7 · Cited by 23
Zhou, S., Zhu, Y., Mashrah, M. A., Zhang, X., He, Z., Yao, Z., Zhang, C., Guo, F. H., Hu, Y., & Zhang, C. (2016) · Oncology Reports · doi:10.3892/or.2016.5307 · Cited by 21
Ayala‐Calvillo, E., zquez, L. M. ⁄., ⁄, A. G. ⁄. A., & lez‐Maya, L. G. ⁄. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7853 · Cited by 21
“The VEGF and MMP-7 mRNA levels were notably reduced following treatment in CaSki and KATOIII cells, while no alteration was observed in HFF (Fig.”
InfluentialHarrison, K. S., Zhu, L., Thunuguntla, P., & Jones, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230870 · Cited by 24
“For example, dysregulation of the Wnt/ β-catenin pathway is crucial for development of certain types of cancer [59] : conversely, the same pathway mediates neurogenesis and cell survival in the nervous system [28, 29] .”
BackgroundUnderstanding the autophagic functions in cancer stem cell maintenance and therapy resistance
Niharika, N., & Garg, M. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.23 · Cited by 25
“81 ).”
Dunn, S.-J., Osborne, J. M., Appleton, P. L., & Näthke, I. S. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-12-0854 · Cited by 22
“Mutations that stimulate Wnt signaling are common to almost all human tumors in intestinal tissue (Schneikert and Behrens, 2007; Polakis, 2012).”
BackgroundBiswas, S., Emond, M. R., Chenoweth, K. P., & Jontes, J. D. (2021) · iScience · doi:10.1016/j.isci.2021.102932 · Cited by 18
“, 2016) to neurodevelopmental disorders and to cancer (Berx and van Roy, 2009; Polakis, 2012; van Roy, 2014; Zhan et al., 2017).”
BackgroundMirghani, H., Ugolin, N., Ory, C., Goislard, M., Lefèvre, M., Baulande, S., Hofman, P. M., Guily, J. L. S., Chevillard, S., & Lacave, R. (2016) · Head & Neck · doi:10.1002/hed.24487 · Cited by 20
Pharmacophore Model for Wnt/Porcupine Inhibitors and Its Use in Drug Design
Poulsen, A., Ho, S. Y., Wang, W., Alam, J., Jeyaraj, D. A., Ang, S. H., Tan, E. S. W., Lin, G. R., Cheong, V. W. W., Ke, Z., et al. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00159 · Cited by 20
Henry, C. E., Emmanuel, C., Lambie, N., Loo, C. K. C., Kan, B., Kennedy, C. J., DeFazio, A., Hacker, N. F., & Ford, C. E. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.014 · Cited by 20
“Evidence of altered Wnt signaling is frequently found in human cancers [1].”
BackgroundThe role of the NORE1A tumor suppressor in Oncogene-Induced Senescence
Barnoud, T., Schmidt, M., Donninger, H., & Clark, G. J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.030 · Cited by 27
“The canonical Wnt signaling pathway is a highly conserved pathway important for tissue development and renewal, and has been shown to be frequently activated in human cancers (79).”
The dichotomy of placenta-derived cells in cancer growth
Silini, A. R., Cancelli, S., Signoroni, P. B., Cargnoni, A., Magatti, M., & Parolini, O. (2017) · Placenta · doi:10.1016/j.placenta.2017.05.011 · Cited by 20
Pereira, A. S. P., Bester, M. J., & Apostolides, Z. (2017) · Molecular Diversity · doi:10.1007/s11030-017-9769-0 · Cited by 20
“Several signaling pathways were also identified and some of these pathways have been found to be dysregulated in cancer as has been observed with the ErbB, vascular endothelial growth factor (VEGF), mitogen-activated protein kinase (MAPK), Ras, phosphatidylinositol-3-kinase (PI3K)-Akt, Rap1, 5’-adenosine monophosphate…”
Piotrowska, Ż., Niezgoda, M., Młynarczyk, G., Acewicz, M., & Kasacka, I. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566637 · Cited by 25
“The Wnt/ß-catenin signaling pathway plays an important role in the process of carcinogenesis (5).”
BackgroundEstimating the predictive power of silent mutations on cancer classification and prognosis
Gutman, T., Goren, G., Efroni, O., & Tuller, T. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00229-1 · Cited by 22
Xue, Y.-L., Guo, Y. N., Liu, N., & Meng, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.2003942 · Cited by 20
“β-catenin, a multifunctional protein, enters the nucleus and regulates gene expression in a free status, in which the abnormality or activation may cause tumors [17,18].”
BackgroundWnt/β-catenin signaling and p68 conjointly regulate CHIP in colorectal carcinoma
Kal, S., Chakraborty, S., Karmakar, S., & Ghosh, M. K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119185 · Cited by 21
LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer
Ma, Y., Yang, D., Li, Q., Zhan, Q., He, X., Liu, S., Zou, H., Corpe, C. P., Chen, L., & Wang, J. (2022) · Discover Oncology · doi:10.1007/s12672-022-00522-0 · Cited by 21
From Nucleus to Organs: Insights of Aryl Hydrocarbon Receptor Molecular Mechanisms
Rejano-Gordillo, C. M., Marín-Díaz, B., Ordiales-Talavero, A., Merino, J. M., González-Rico, F. J., & Fernández‐Salguero, P. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314919 · Cited by 30
“It has been described that Wnt-mediated signaling needs to be in balance in order to obtain a proper development program, as both downregulation and over-signaling of Wnt can lead to several defects [51–53], including lung, breast and skin cancer [54].”
BackgroundAmawi, H. A., Hussein, N. A., Boddu, S. H. S., Karthikeyan, C., Williams, F. E., Ashby, C. R., Raman, D., Trivedi, P., & Tiwari, A. K. (2019) · Cancers · doi:10.3390/cancers11050711 · Cited by 18
“This overactivation and accumulation of β-catenin in the nucleus induces the progression of colon, ovarian, liver, and prostate cancers, among others [10,40,41].”
BackgroundAbrahams, L., Savisaar, R., Mordstein, C., Young, B., Kudla, G., & Hurst, L. D. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab750 · Cited by 22
Taking the road less traveled – the therapeutic potential of CBP/β-catenin antagonists
Kahn, M. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992386 · Cited by 21
“naling is a recurrent theme in cancer stem cells (CSC) and cancer biology more generally [16,17].”
BackgroundTMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway
Chen, J., Wang, D., Chen, H., Gu, J., JIANG, X. H., Han, F., Cao, J., Liu, W., & Liu, J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04363-w · Cited by 22
Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways
Sonawala, K., Ramalingam, S., & Sellamuthu, I. (2022) · Cells · doi:10.3390/cells11213492 · Cited by 19
The diagnostic, prognostic role and molecular mechanism of miR-328 in human cancer
Wang, Z., Xie, W., & Guan, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114031 · Cited by 19
Alsaab, H. O. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154566 · Cited by 22
Shizu, R., Makida, N., Sobe, K., Ishimura, M., Takeshita, A., Hosaka, T., Kanno, Y., Sasaki, T., & Yoshinari, K. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad129 · Cited by 20
Peiffer, L., Poll‐Wolbeck, S. J., Flamme, H., Gehrke, I., Hallek, M. J., & Kreuzer, K. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1689-0 · Cited by 20
“the unnatural activity of the Wnt pathway is involved in the development of several types of cancer (Polakis 2012).”
BackgroundmiR-127 suppresses gastric cancer cell migration and invasion via targeting Wnt7a
Wang, L., Wang, X., & Jiang, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.9955 · Cited by 20
“It is well known that Wnt7a signaling is involved in cancer progression (29).”
BackgroundN-Terminal Domain Mediated Regulation of RORα1 Inhibits Invasive Growth in Prostate Cancer
Park, S. C., Park, I.-G., Kim, H.-K., & Lee, J. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071684 · Cited by 22
The Alteration of CTNNBIP1 in Lung Cancer
Chang, J.-M., Tsai, A. C.-D., Huang, W.-R., & Tseng, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225684 · Cited by 18
Liu, X., Liu, C., Chen, C., Sun, W., Ci, Y., Li, Q., & Song, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s247646 · Cited by 19
PowerfulDrosophilascreens that paved the wingless pathway
Jenny, F. H., & Basler, K. (2014) · Fly · doi:10.4161/19336934.2014.985988 · Cited by 21
MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway
Akiva, İ., & İyison, N. B. (2018) · BMC Cancer · doi:10.1186/s12885-017-3960-7 · Cited by 20
“In addition to these mutations, the nuclear accumulation of β-catenin due to aberrant activation of Wnt signaling is mainly observed in hepatocellular, colorectal, gastrointestinal, and breast tumors [10].”
Zarei, N., Fazeli, M., Mohammadi, M., & Nejatollahi, F. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4641-6 · Cited by 19
Hsa-miR-942 fingerprint in colorectal cancer through Wnt signaling pathway
Fasihi, A., Soltani, B. M., Ranjbaran, Z. S., Bahonar, S., Norouzi, R., & Nasiri, S. (2019) · Gene · doi:10.1016/j.gene.2019.143958 · Cited by 18
Kumar, N., Mondal, M., Arathi, B. P., Sundaresan, N. R., & Somasundaram, K. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194900 · Cited by 21
Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
Lozano, E., Sanchon-Sanchez, P., Morente-Carrasco, A., Chinchilla-Tábora, L. M., Mauriz, J. L., Fernández‐Palanca, P., Marín, J. J. G., & Macías, R. I. R. (2023) · Cells · doi:10.3390/cells12081141 · Cited by 20
“This type of mutation has been found in HCC with a frequency of ≈19% [38].”
BackgroundUnraveling the dangerous duet between cancer cell plasticity and drug resistance
Chatterjee, N., Pulipaka, B., Subbalakshmi, A. R., Jolly, M. K., & Nair, R. (2023) · Computational and Systems Oncology · doi:10.1002/cso2.1051 · Cited by 22
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.